Genoox vs FORE Biotherapeutics

Genoox vs FORE Biotherapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Genoox is on 62/100 and FORE Biotherapeutics on 56/100.

Genoox logo
GenooxGenoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.
Try Genoox
FORE Biotherapeutics logo
FORE BiotherapeuticsPrecision oncology company developing cancer therapies guided by proprietary functional genomics.
Try FORE Biotherapeutics

Where each one leads

Genoox

  • our overall score: 62/100 against 56/100
  • domain rating: 50/100 against 33/100
  • headcount growth: +10.7% against +8.2%

FORE Biotherapeutics

  • funding raised: $232M against $20.0M

At a glance

MeasureGenooxFORE Biotherapeutics
What it isGenoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.Precision oncology company developing cancer therapies guided by proprietary functional genomics.
CategoryHealthcare, Genomics, Genomic Data, Next Generation SequencingHealthcare, Drug Development, Genomics, Next Generation Sequencing
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded20142011
HeadquartersPalo Alto, United StatesPhiladelphia, United States
StatusActiveActive

Size, funding and growth

MeasureGenooxFORE Biotherapeutics
Employees5356
Headcount growthLast 12 months+10.7%+8.2%
Total funding$20.0M$232M
Latest roundSeries CSeries D-2 Extension
ValuationNot published$75.0M
LinkedIn followers3,9024,584

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureGenooxFORE Biotherapeutics
StartupHub scoreOur 0-100 rating62/10056/100
Traction54/10058/100
Team70/10070/100
Community8/100Not published
Search visibility32/10038/100
Quality68/10055/100
Agent readinessHow well an AI agent can read and act on the siteF (38/100)F (37/100)
Domain ratingLink authority, 0-10050/10033/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureGenooxFORE Biotherapeutics
CDNCloudflareNot detected
CMSNot detectedWordPress
FrameworksAngularJquery

Genoox vs FORE Biotherapeutics: common questions

Which is better, Genoox or FORE Biotherapeutics?

On our 0-100 score Genoox rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do Genoox and FORE Biotherapeutics compare on the numbers?

Genoox leads on our overall score (62/100 against 56/100), domain rating (50/100 against 33/100), headcount growth (+10.7% against +8.2%). FORE Biotherapeutics leads on funding raised ($232M against $20.0M).

Read the full Genoox review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other Genoox alternatives we track.